Literature DB >> 35086641

In Reply.

Conrad Genz, Ruediger C Braun-Dullaeus.   

Abstract

Entities:  

Year:  2021        PMID： 35086641      PMCID： PMC8820081          DOI： 10.3238/arztebl.m2021.0302

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

2.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

3.  Inhibition of Platelet Aggregation After Coronary Stenting in Patients Receiving Oral Anticoagulation.

Authors:  Conrad Genz; Ruediger C Braun-Dullaeus
Journal:  Dtsch Arztebl Int       Date:  2021-06-04       Impact factor: 5.594

4.  Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Davide Capodanno; Marco Di Maio; Antonio Greco; Deepak L Bhatt; C Michael Gibson; Andreas Goette; Renato D Lopes; Roxana Mehran; Pascal Vranckx; Dominick J Angiolillo
Journal:  J Am Heart Assoc       Date:  2020-08-01       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.